Microbial identification and drug susceptibility analysis system test board

Product use: It can be used for the identification of clinical pathogenic bacteria and semi-quantitative analysis of MIC of antibacterial drugs

Product advantages

1. Complete variety and wide range of identification

Newly added detection of Neisseria, Haemophilus, Listeria and other species, covering common clinical bacteria and rare bacteria

2. Unique detection reagents

The domestic exclusive launch of Streptococcus test board containing Optochin (Optoxin), Bacitracin (Bacitracin), G+ cocci test board containing DAP (Daptomycin)

3. Bright colors and stable quality

Using imported SIGMA, OXOID raw materials, freeze-vacuum drying process for coating to ensure stable product quality

4. The drug gradient is wider, and the MIC value can be reported more accurately

With a 120-well plate, more than 30 drugs can be tested in the same test plate, covering all the latest CLSI breakpoints

5. Reasonable drug selection covers more new drugs

Update drug types and concentration gradients according to CLS standard documents, including 4 ESBL confirmed test drugs that meet CLSI requirements

• Contains tigecycline - for XDR bacteria, more accurate results and more stable reagents
• Contains daptomycin - the world's first cycloaliphatic phthalate antibiotic, a new type of G+ bacteria fungicide, targeting MRSA, VISA, VRE
• Contains linezolid - good antibacterial effect against multi-drug resistant gram-positive bacteria, against MVRSA.VISA, VRE PRSP
• Contains moxifloxacin - can cover common pathogens and atypical pathogens of CAP